GREM1 and benign neoplasm: Real-time PCR analysis showed that GREM1 expression was higher in malignant tumors, such as BCCs (P < 0.05) and SCCs (P < 0.01) than in benign tumors, such as EPs, HDAs, and SPAs (Fig 2A).